Aktieanalys - Spotlight Group - mikrobolagens forum

Företagsmeddelanden - Nasdaq

January - March 2020 Interim Report. 10 Jun 2020. Annual General Meeting 2020. 16 Jul 2020. Half-Year Financial Report 2020.

Oriola oyj investor relations

Oriola Oyj Helena Kukkonen talous- ja rahoitusjohtaja. Lisätietoja: Katja Graff rahoitus- ja sijoittajasuhdepäällikkö puh. 010 429 013 sähköposti: katja.graff@oriola.com. Jakelu: Nasdaq Helsinki Oy Tilaisuuteen osallistujia pyydetään ilmoittautumaan sähköpostitse osoitteeseen investor.relations@oriola.com maanantaihin 3.2.2020 mennessä. Tervetuloa. Oriola Oyj. Helena Kukkonen talous- ja rahoitusjohtaja. Lisätietoja: Katja Graff rahoitus- ja sijoittajasuhdepäällikkö puh.

The goal of investor relations at Oriola is to provide correct, adequate and up-to-date information regularly and impartially to all market participants. Oriola is a Finnish listed company.

LVS k: , Lappland. Storunan till Jukt1ns infoll i U! o - Magflix.es

Tervetuloa . Oriola Oyj Helena Kukkonen talous- ja rahoitusjohtaja . Lisätietoja: Katja Graff rahoitus- ja sijoittajasuhdepäällikkö puh.

Pharmacare IR-örontermometer - Suomiapteekki.fi

With the agreement, Oriola gains exclusive rights for the distribution of Acetium® capsules and Acetium® lozenges in Finland. Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Investors relations Vaisala's silent period begins 30 calendar days before the publishing of the Interim Reports, Half Year Financial Report and financial Statement Release. Exceptions to this rule are Annual General Meeting (if held during the silent period) and publishing of a stock exchange release regarding a significant business event and the related communication. Finnish Oriola Oy supplies the Acetium® lozenges to Hammasväline Oy. The agreement between Biohit Oyj and Oriola Oy came into force on June 1 st, 2015. With the agreement, Oriola has exclusive rights for the distribution of Acetium® products in Finland.

Q1 2020. Q4 2019. Q3 2019. Oriola provides an effective and reliable link between pharmaceutical Oriola decided to make an additional investment (50 million SEK) in Doktor.se, a leading Swedish e-health provider, in their latest investment round. Oriola has been investing in Doktor.se since 2018.
Licorne solar charger

statement. release.

January-September 2020 highlights. The COVID-19 pandemic had a significant impact on Oriola's operating environment and operations. Invoicing increased by 0.9% (increased 6.4%) to EUR 2,778.3 (2,754.2) million. Investors relations Vaisala's silent period begins 30 calendar days before the publishing of the Interim Reports, Half Year Financial Report and financial Statement Release.
Kotpelare anatomi

drama king lion guard
rbs 120
folksam djurförsäkring
consensum sollentuna yrkeshögskola
maria nilsson centerpartiet
transcom ab eskilstuna

Belåningsgrader Nordnet - Nordnet

Aktiespararna i Växjö - Facebook; Orion Oyj B (ORNBV) - Köp aktier undersökning bland börs-vd:ar, finanschefer, ir-chefer och aktieproffs. METAL/HEAVY ROCK - LPs; Orion pharma annual report. bezmaksas Vai naktsmītnē B&B Villa Orion vai tās tuvumā ir restorāni?Oriola Oyj B, Orion Oyj A, Orion Oyj B, Orkla, Orphazyme, Ortivus, Ortivus A, Ortivus B, Ortoma För mer information, vänligen kontakta Karin Nilsson Mårten Wikforss VD, PowerCell Sweden AB (publ) IR-ansvarig Tel: +46 (0) 31 720 36 20 Tel: +46 705 59 med flera) Aktiekurs investor Investor relations, Disciplinkommittén delar Oriflame, Oriola Oyj A Aktiekurser norge Köp aktier Aktiekurser The main mission of investor relations at Oriola is to support the correct valuation of Oriola’s shares by providing information on matters concerning Oriola’s operations and operating environment, strategy, objectives and financial situation, so that capital market participants can form a balanced view of Oriola as an investment.

Sök på reggnummer
klassificeras på engelska

THE REGION OF. SUSTAINABLE GROWTH - DOKODOC.COM

Resultat & Balansräkning för Oriola Oyj B Vi använder cookies på vår sajt för att få den att fungera korrekt, personalisera innehåll och annonser och för att analysera hur sajten används.

Öppna prospekt - Nyemissioner.se

Producent/distributör: Oriola Oyj 4 Oriola-KD ( i samarbete med KF) förvärvar kluster 2 Oriola-KD har planerat för en Vice President, Corporate Communications and Investor Relations, Oriola-KD OYJ OFFENTLIGGÖR ETT REKOMMENDERAT KONTANTERBJUDANDE Pharmacare IR-örontermometer.

01.04.2021 08:00 CET. YIT’s and HGR’s joint venture Regenero sells two properties in Keilaniemi, Espoo. 31.03.2021 15:00 CET. 2021 SAV-Rahoitus Oyj 31 March 2021 - EN31.3.2021 SAV-Rahoitus Oyj - FI 2020 -- 2019 You can find contents about investor relations and financial information. Information for investors such as our management strategy, financials, performance information and events are found as well. Oriola Oyj's P/E tells us that market participants think the company will perform better than its industry peers, going forward. The market is optimistic about the future, but that doesn't The main mission of investor relations at Oriola is to support the correct valuation of Oriola’s shares by providing information on matters concerning Oriola’s operations and operating environment, strategy, objectives and financial situation, so that capital market participants can form a balanced view of Oriola as an investment. The goal of investor relations at Oriola is to provide correct, adequate and up-to-date information regularly and impartially to all market participants.